News Author: Karen Blum Publish date: December 3, 2015
News Author: Karen Blum Publish date: December 3, 2015
Within 1 month after vaccination, the seroprotection rate against all influenza strains was above the recommended threshold level of 1:40 in more than...
News Author: Karen Blum Publish date: December 1, 2015
News Author: Karen Blum Publish date: November 24, 2015
News Author: Karen Blum Publish date: November 18, 2015
News Author: Karen Blum Publish date: June 12, 2015
Key clinical point:If preliminary findings are confirmed, methylation level profiling could lead to the identification of patients who are not goo...
News Author: Karen Blum Publish date: June 12, 2015
News Author: Karen Blum Publish date: June 12, 2015
News Author: Karen Blum Publish date: June 11, 2015
Key clinical point: Alterations in gut microbiota of patients with systemic sclerosis are suspected to contribute to the immune dysfunction and ga...
News Author: Karen Blum Publish date: November 15, 2014
Key clinical point: Sofosbuvir plus GS-5816 was well tolerated and achieved high SVR12 rates among treatment-naive patients with chronic genotype ...
News Author: Karen Blum Publish date: November 15, 2014
Key clinical point: Sofosbuvir plus GS-5816 was well tolerated and achieved high SVR12 rates among treatment-naive patients with chronic genotype ...
News Author: Karen Blum Publish date: November 9, 2014
Key clinical point: Viral suppression in HCV-infected patients improved neural health as measured by magnetic resonance spectroscopy.
Major findin...
News Author: Karen Blum Publish date: November 9, 2014
Key clinical point: Sofosbuvir plus GS-5816 was well tolerated and achieved high SVR rates among treatment-naive patients with chronic genotype 3 ...
News Author: Karen Blum Publish date: November 9, 2014
Key clinical point: A formulation of ABT-450 with ritonavir, ombitasvir, and dasabuvir, given with ribavirin, can yield sustained viral response t...
News Author: Karen Blum Publish date: November 3, 2014
Key clinical point: Patients with chronic hepatitis C genotype 1 infection who relapse after sofosbuvir/ribavirin treatment may be successfully re...
